Search

everythinglearnresearchcommunity

for

Search:↓

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

NEMO syndrome and systemic lupus erythematosus are linked in a new disease association.

Finasteride is considered the best treatment for hair loss, despite side effects.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Using existing drugs for new treatments is cost-effective and safer.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Spironolactone is effective and safe for treating acne in women, especially those over 25 with hormonal imbalances.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Antibiotics often cause skin reactions, making them a major health concern.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

No cure exists for alopecia areata, and treatments are personalized.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.